We are live on
!
Find out more
BFM
Boothbay Fund Management Portfolio holdings
AUM
$7.71B
1-Year Est. Return
106.29%
This Fund
S&P 500
This Quarter
Est. Return
+15.01%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$6.7B
AUM Growth
-$175M
(-2.5%)
Cap. Flow
-$285M
Cap. Flow
% of AUM
-4.26%
Top 10 Holdings %
Top 10 Hldgs %
24.91%
Holding
2,523
New
688
Increased
486
Reduced
584
Closed
615
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vaxcyte
PCVX
|
+$16.5M |
| 2 |
Motorola Solutions
MSI
|
+$15.5M |
| 3 |
Rocket Companies
RKT
|
+$15.4M |
| 4 |
Visa
V
|
+$14.6M |
| 5 |
Wyndham Hotels & Resorts
WH
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cornerstone Strategic Value Fund
CLM
|
+$42.4M |
| 2 |
Lumentum
LITE
|
+$25.8M |
| 3 |
Home Depot
HD
|
+$23.8M |
| 4 |
Walmart Inc
WMT
|
+$22.8M |
| 5 |
Ciena
CIEN
|
+$19.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.49% |
| 2 | Healthcare | 9.98% |
| 3 | Consumer Discretionary | 7.16% |
| 4 | Industrials | 6.43% |
| 5 | Financials | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Vista Gold
VGZ
$309M
| $55.3K | ﹤0.01% |
+28,093
| New | +$54.2K |
|
1802
Tronox
TROX
$1.05B
| $54.8K | ﹤0.01% |
13,151
-63,619
| -83% | -$242K |
|
1803
Cosan
CSAN
$2.84B
| $54.7K | ﹤0.01% |
+13,855
| New | +$63.1K |
|
1804
FerroAtlántica
GSM
$826M
| $54.5K | ﹤0.01% |
+11,749
| New | +$54.2K |
|
|
NEUP
1805
Neuphoria Therapeutics
NEUP
$20.9M
| $54.3K | ﹤0.01% |
+14,000
| New | +$99.5K |
|
|
PGACR
1806
Pantages Capital Acquisition Corp Right
PGACR
| $52.9K | ﹤0.01% |
264,000
| – | – |
|
|
NYXH
1807
Nyxoah
NYXH
$144M
| $52.8K | ﹤0.01% |
11,474
-3,269
| -22% | -$16.8K |
|
1808
GlucoTrack
GCTK
$3.27M
| $52.3K | ﹤0.01% |
+13,525
| New | +$80.3K |
|
1809
SELLAS Life Sciences
SLS
$2.37B
| $52K | ﹤0.01% |
+13,800
| New | +$26.8K |
|
|
NKLR
1810
Terra Innovatum Global N.V.
NKLR
$635M
| $51K | ﹤0.01% |
+11,044
| New | +$77.5K |
|
1811
Lexicon Pharmaceuticals
LXRX
$1.04B
| $51K | ﹤0.01% |
44,315
-11,805
| -21% | -$16.2K |
|
1812
Clover Health Investments
CLOV
$2.54B
| $49.8K | ﹤0.01% |
21,189
-41,961
| -66% | -$115K |
|
1813
ZipRecruiter
ZIP
$426M
| $49.6K | ﹤0.01% |
12,721
-542
| -4% | -$2.44K |
|
1814
Xerox
XRX
$429M
| $49.2K | ﹤0.01% |
20,765
+9,440
| +83% | +$27.9K |
|
|
RZLV
1815
Rezolve AI
RZLV
$1.08B
| $49.1K | ﹤0.01% |
19,108
| – | – |
|
|
ITRG
1816
Integra Resources
ITRG
$511M
| $48K | ﹤0.01% |
11,976
-13,695
| -53% | -$46.2K |
|
|
IGR
1817
CBRE Global Real Estate Income Fund
IGR
$710M
| $47.7K | ﹤0.01% |
+10,883
| New | +$51.2K |
|
|
YARW
1818
Yarrow Bioscience, Inc. Common Stock
YARW
$118M
| $47.2K | ﹤0.01% |
1,627
-502
| -24% | -$10.1K |
|
1819
Ultrapar
UGP
$6.59B
| $46.7K | ﹤0.01% |
+12,379
| New | +$49K |
|
|
RZLVW
1820
Rezolve AI Warrants
RZLVW
$5.81M
| $46.6K | ﹤0.01% |
18,134
-48,425
| -73% | -$57.9K |
|
|
BKHAR
1821
Black Hawk Acquisition Corp Rights
BKHAR
| $46K | ﹤0.01% |
35,375
| – | – |
|
|
PEW.WS
1822
GrabAGun Digital Holdings Warrants
PEW.WS
| $45.4K | ﹤0.01% |
15,072
-17,342
| -54% | -$15.9K |
|
1823
Palladyne AI
PDYN
$296M
| $43.7K | ﹤0.01% |
+10,257
| New | +$69K |
|
1824
BTCS Inc
BTCS
$57.2M
| $42.1K | ﹤0.01% |
+15,937
| New | +$57.5K |
|
1825
Blend Labs
BLND
$414M
| $41.5K | ﹤0.01% |
13,661
-159,899
| -92% | -$510K |
|
Similar funds
MAM
SIAU
WRCM
IMCOOI
CCM
PGFC
AMH
SF
Boothbay Fund Management's Q4 2025 Portfolio in Review
As of Q4 2025, Boothbay Fund Management held 2,523 positions worth $6.7B, down 2.5% from $6.88B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Boothbay Fund Management withdrew a net $285M in Q4 2025, closing 615 positions and reducing 584 holdings. Its most notable exit was Mr. Cooper, an estimated $18.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Boothbay Fund Management opened a new position in Visa worth $15M.
- Boothbay Fund Management's largest Q4 2025 buy was Visa: 42,763 shares worth $15M.
- Boothbay Fund Management added most to Vaxcyte in Q4 2025, an estimated $16.5M increase.
- Boothbay Fund Management's biggest Q4 2025 reduction was Cornerstone Strategic Value Fund, cutting an estimated $42.4M.
- Boothbay Fund Management fully exited Mr. Cooper in Q4 2025, selling an estimated $18.1M.
- Boothbay Fund Management's ten largest holdings make up 25% of its $6.7B portfolio in Q4 2025.
- Boothbay Fund Management opened 688 new positions and closed 615 in Q4 2025.
- Boothbay Fund Management's portfolio value fell 2.5% quarter-over-quarter to $6.7B.
Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.